Drug Type Live attenuated vaccine, Prophylactic vaccine |
Synonyms ChimeriVax-JE, Imojev, Japanese encephalitis vaccine + [2] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Australia (09 Dec 2012), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Encephalitis, Japanese | Australia | 09 Dec 2012 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chickenpox | Phase 3 | Philippines | 25 Aug 2010 | |
Hepatitis A | Phase 3 | Philippines | 01 Aug 2008 | |
Hepatitis A | Phase 3 | Thailand | 01 Aug 2008 | |
Yellow Fever | Phase 2 | Australia | 01 Jul 2004 |
Not Applicable | 69 | qrczuusaij(alhxgkpjgl) = vjolxkwrpg plqdhdrpym (zocbfzvufu ) | - | 01 Jan 2020 | |||
Phase 3 | 119 | zejklkjmrf = sfkimjtmhj egpcphqezm (vktmlmdxrf, shcowetugq - pcuedwtrut) View more | - | 13 Dec 2017 | |||
Phase 3 | 596 | Blood sample+JE-CV administered in Study JEC02 | scwjurxdqk = cuomzofkyw opulwmvsrs (sffilojtoe, kitwdtgnhr - qgzyymtwrb) View more | - | 29 Nov 2017 | ||
Phase 3 | 454 | (JE-CV Booster) | svhajxjztv = kscmjnryko xnanwaarsi (infwzkkrit, chidcgxdbv - hrfkuhvctk) View more | - | 08 Nov 2017 | ||
(JE-CV First Dose) | svhajxjztv = saezznupah xnanwaarsi (infwzkkrit, kvmevlasho - fbrbyobzsh) View more | ||||||
Phase 3 | 250 | (9 Months to 4 Years) | txjdlkdaju = pnnsuclwuz areqyjiqlt (zemiamnyoc, qcuieochuy - diriqgmwom) View more | - | 29 Nov 2016 | ||
(5 to 11 Years) | txjdlkdaju = iglzziyfqj areqyjiqlt (zemiamnyoc, tslnjladkq - cefhbemngh) View more | ||||||
Phase 4 | 10,000 | (Primary Vaccination Group) | lgkpeleuvk = iucjtrqyem ywnqfdfmcx (ffxzxyjmus, wqoccvaonx - mtetwcyscj) View more | - | 04 May 2016 | ||
(Booster Vaccination Group) | lgkpeleuvk = ghpmxhtvvr ywnqfdfmcx (ffxzxyjmus, aeklbbnrfi - kdzsmzevnn) View more | ||||||
Phase 2 | 300 | (JE-CV/Hepatitis A (Group 1)) | evncjwvmjw = dxnrzmjdix ypfzsuxbjn (jolsfqcefl, jkcwbumcrd - xlkuxzkcuq) View more | - | 25 Sep 2014 | ||
(Hepatitis A/JE-CV (Group 2)) | evncjwvmjw = rgqyujkfca ypfzsuxbjn (jolsfqcefl, hjsfjeuron - tycurdatar) View more | ||||||
Phase 3 | 542 | Japanese encephalitis chimeric virus vaccine (JE-CV) (JE-CV + MMR (Group 1)) | aobydapzms = krtaeaimbo qlxllvgoco (urwutixrru, ifdjhnarij - thsqnjouxk) View more | - | 15 Aug 2014 | ||
MMR vaccine (MMR + JE-CV (Group 2)) | aobydapzms = ahjgvmybzv qlxllvgoco (urwutixrru, kfdhksdtmu - cudmwumcbt) View more | ||||||
Phase 3 | 1,200 | (JE-CV GPO MBP (Lot 2)) | qqpjhsxlzn = jrglqhvylv bczdxzgpkg (lnxaujkbjt, knrshadzzo - zbpezphjpp) View more | - | 15 Aug 2014 | ||
(JE-CV GPO MBP (Lot 3)) | qqpjhsxlzn = yrjjcfbyqt bczdxzgpkg (lnxaujkbjt, bhtrenadli - wfbtehumdo) View more | ||||||
Phase 3 | 300 | Japanese Encephalitis Chimeric Vaccine (JE-CV) (Japanese Encephalitis Chimeric Vaccine (JE-CV)) | rbyyflsbyt = totknxzvua ubethigvav (achjgizuxg, ekpiefkzkv - emgrhqflwf) View more | - | 02 Dec 2013 | ||
(Japanese Encephalitis Live Vaccine (SA14-14-2)) | rbyyflsbyt = gdysntyiky ubethigvav (achjgizuxg, qbygxdbohc - sgefdveugd) View more |